Vaccines against diarrheal diseases.
At least 2 million persons succumb annually to enteric infection, and in countless other patients, diarrheal disease aggravates malnutrition and susceptibility to other infections. Prevention of enteric illness by virtue of improved hygiene and provision of sanitation and water treatment is impractical in most developing countries, where morbidity and mortality rates are highest. For this reason, development of vaccines against the most important gastrointestinal infections remains a high priority.
Nataro
James P
JP
University of Maryland, School of Medicine, Center for Vaccine Development, 685 W. Baltimore St, Baltimore, MD 21201, USA. jnataro@medicine.umaryland.edu
D001424:Bacterial Infections / Q000276:immunology / Q000517:prevention & control; D001428:Bacterial Vaccines / Q000276:immunology*; D002167:Campylobacter / Q000276:immunology; D002648:Child; D022121:Cholera Vaccines / Q000276:immunology; D003967:Diarrhea / Q000382:microbiology / Q000517:prevention & control* / Q000821:virology; D022361:Escherichia coli Vaccines / Q000276:immunology; D006801:Humans; D022243:Rotavirus Vaccines / Q000276:immunology; D022562:Salmonella Vaccines / Q000276:immunology; D022281:Shigella Vaccines / Q000276:immunology; D014765:Viral Vaccines / Q000276:immunology*
D001428:Bacterial Vaccines; D022121:Cholera Vaccines; D022361:Escherichia coli Vaccines; D022243:Rotavirus Vaccines; D022562:Salmonella Vaccines; D022281:Shigella Vaccines; D014765:Viral Vaccines